Esperanza N.
- Country
- Spain
- Department
- Rheumatology
Research Overview
- Phase I/II Study of QEL-005 Autologous CD19-Targeting CAR T-Regulatory Cell Therapy in Patients with Diffuse Cutaneous Systemic Sclerosis and Difficult-to-Treat Rheumatoid Arthritis
- Efficacy and Safety Evaluation of KPL-404 in a Phase 2 Randomized, Double-blind, Placebo-controlled Study for Sjögren’s Disease
- Efficacy and Safety Evaluation of Efgartigimod Alfa Subcutaneous Injection in Adult Patients with Primary Sjögren’s Disease: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 15 of 107 partner sites.
Specializations
Autoimmune Disorders
The investigator specializes in treating Sjögren's Disease, focusing on innovative therapeutic approaches for both primary and systemic manifestations of this condition.
- Systemic disease activity management
- Novel immunomodulatory therapies
- Treatment of systemic complications
Particular emphasis is placed on evaluating emerging treatments that target specific immune system pathways involved in Sjögren's Disease progression.
Rheumatic Conditions
The investigator has developed expertise in treating acute gout flares, with a focus on innovative approaches to pain management and inflammation control.
- Acute pain management
- Anti-inflammatory interventions
- Joint function preservation
Research interests include evaluating rapid-acting therapeutics for acute gout episodes and their impact on patient mobility and quality of life.
Clinical Immunology
The investigator focuses on immunomodulatory treatments for autoimmune conditions, with particular attention to subcutaneous therapeutic applications.
- Targeted immune response modification
- Disease activity monitoring
- Long-term disease management
Special interest in developing therapeutic strategies that address both local and systemic manifestations of autoimmune disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.